Transcription of ICH guideline E6 on good clinical practice
{{id}} {{{paragraph}}}
24 June 2021 EMA/CHMP/ICH/337843/2021 Committee for Medicinal Products for Human Use ICH guideline E6 on good clinical practiceDraft ICH E6 principles Transmission to CHMP 24 June 2021 Release for information 24 June 2021 Official address Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands Address for visits and deliveries Refer to Send us a question Go to Telephone +31 (0)88 781 6000 An agency of the European Union European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged. 19 April 2021 ICH-E6 good clinical practice (GCP) Explanatory Note The International Council for Harmonisation (ICH) is committed to developing timely technical requirements for pharmaceuticals for human use in a manner that is responsive to the needs of the global community.
ICH-E6 Good Clinical Practice (GCP) Explanatory Note . The International Council for Harmonisation (ICH) is committed to developing timely technical requirements for pharmaceuticals for human use in a manner that is responsive to the needs of the global community. ICH is committed to stakeholder engagement and transparency in the development
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}